SCHEMBL19984569

SCHEMBL19984569

Nc1cc(Br)ccc1SN1CCCCC1C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 2/20 0.38
ALDH1A1 P00352 7/20 0.35
KDM4E B2RXH2 2/20 0.34
GLA P06280 1/20 0.34
GHSR Q92847 1/20 0.34
MAPT P10636 2/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HTT P42858 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
GRK2 P25098 1/20 0.32
CASP6 P55212 1/20 0.32
CASP8 Q14790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19984522 0.96 ALDH1A1 (0.38) AAK1ALDH1A1KDM4EGLAMAPT
SCHEMBL19984595 0.86 ALDH1A1 (0.44) AAK1ALDH1A1KDM4EMAPTKMT2A
SCHEMBL19984699 0.82 ALDH1A1 (0.47) AAK1ALDH1A1KDM4EKMT2AHTT
SCHEMBL19984568 0.72 ALDH1A1 (0.49) ALDH1A1KDM4EGHSRPOLBHTT
SCHEMBL19975006 0.68 HCRTR1 (0.52) ALDH1A1KDM4EPOLBHTTSMN1; SMN2
SCHEMBL19975007 0.68 HCRTR1 (0.52) ALDH1A1KDM4EPOLBHTTSMN1; SMN2
SCHEMBL3643939 0.66 ALDH1A1 (0.48) ALDH1A1POLBSMN1; SMN2
SCHEMBL9473812 0.66 ALDH1A1 (0.48) ALDH1A1POLBSMN1; SMN2
SCHEMBL7644709 0.65 ALDH1A1 (0.47) ALDH1A1POLBSMN1; SMN2
SCHEMBL22798963 0.65 BRS3 (0.44) ALDH1A1GHSRMAPTKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018053157-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES, INC. (US) 2018-03-22 WO disclosed